NCT03796013View on ClinicalTrials.gov

A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

February 6, 2019

Study Completion Date

February 6, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Entrectinib Form A

Participants will receive a single oral dose of entrectinib form A under fasted conditions.

DRUG

Entrectinib Form C

Participants will receive a single oral dose of entrectinib form C under fasted conditions.

Trial Locations (1)

75247

Covance Research Unit - Dallas, Dallas

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT03796013 - A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects | Biotech Hunter | Biotech Hunter